US: Drug slows Alzheimer’s development by 35% in trial 3 min read Health US: Drug slows Alzheimer’s development by 35% in trial 5 months ago Chicago: An experimental Alzheimer’s drug developed by Eli Lilly and Co slowed cognitive decline by 35% in a intently watched, late-stage trial, the corporate mentioned... Read More
US: Drug slows Alzheimer’s development by 35% in trial 
Darkish tea useful for controlling blood sugar: Research 
New most cancers implant know-how may slash deaths by 50% 
Worldwide Espresso Day: 6 enjoyable information about espresso